Resources

Commissioner

NHS England, CCGs and local authorities are all responsible for commissioning different parts of hepatitis C testing, treatment and care.  Find here tools, templates and other relevant documents to assist commissioners with their responsibilities to ensure hepatitis C patients are diagnosed and receive high quality care.

Showing 41 to 50 of 260 resources

  • Equity and excellence: Liberating the NHS
    This White Paper sets out the long-term plan for the NHS in this Parliamentary term and beyond. The Government states that it will give the NHS a coherent, stable, enduring framework for quality and service improvement. It aims for the debate on health to no longer be about structures and processes, but about priorities and progress in health improvement for all. This is a challenging and far-reaching set of reforms, which will drive cultural changes in the NHS. It sets out plans for managing change, including the transitional roles of strategic health authorities and primary care trusts.
    England Jul 2010 Other PDF
  • Evaluation of the pilot provision of single use plastic water ampoules to people who inject drugs in Glasgow
    Greater Glasgow and Clyde (GG&C) has an estimated injecting population of 8862. There are 74 Injecting Equipment Provision (IEP) outlets across the area to meet the paraphernalia needs of this population. Since 2009 GG&C has provided a comprehensive package of paraphernalia, including needle choice, spoons, filters, citric acid and swabs. However, until the start of this pilot, water for injecting (WFI) was not available from any of the 62 pharmacy outlets. In fact prior to the pilot only 3 outlets provided WFI and this was in a glass ampoule form.
    Scotland Sep 2012 Case study, Reports & Research PDF
  • Eye of the Needle: United Kingdom Surveillance of Significant Occupational Exposures to Bloodborne Viruses in Healthcare Workers
    This report summarises data collected for healthcare workers (HCWs) occupationally exposed to human immunodeficiency virus (HIV), hepatitis B and hepatitis c (HCV) in England, Wales and Northern Ireland. It examines the types of exposures, the staff involved and the circumstances surrounding exposure episodes and uses such information to inform the development of national prevention policies and to monitor the implementation of current guidelines. Section 2.6 explores Hepatitis C related exposures.
    UK Nov 2008 Reports & Research PDF
  • Face It: Hepatitis C Best Practice - Developing a local hepatitis C strategy
    Dr Erika Duffell, Consultant in Health Protection at Greater Manchester Health Protection Unit (HPU) led a project on behalf of the local Primary Care Trusts (PCTs) to improve services for the prevention, diagnosis and treatment of hepatitis C in Greater Manchester. A steering group produced a comprehensive needs assessment and evidence-based strategy, which convinced PCT commissioners to invest in services. So far, the programme has led to the development of outreach clinics in local drug services, the recruitment of extra medical and nursing staff to treat
    North West 2008 Tools & Templates, Strategy & Planning PDF
  • Fact-sheet on alcohol-related liver disease and hepatitis C
    Developed by the Hepatitis C Coaltiion on the basis of interviews with patient and clinical experts, as well as drawing upon the expertise within the Hepatitis C Coalition’s membership, this fact-sheet provides an overview of the linkages between hepatitis C and alcohol-related liver disease. As well as detailing the interactions between the two conditions, it also details the health impact, as well as the latest relevant policy developments.
    UK Aug 2015 Other, Reports & Research PDF
  • Fact-sheet on haemophilia and hepatitis C
    Developed by the Hepatitis C Coaltiion on the basis of interviews with patient and clinical experts, as well as drawing upon the expertise within the Hepatitis C Coalition’s membership, this fact-sheet provides an overview of the linkages between hepatitis C and haemophilia. As well as detailing the interactions between the two conditions, it also details the health impact, as well as the latest relevant policy developments.
    UK Aug 2015 Other, Reports & Research PDF
  • Fact-sheet on HIV and hepatitis C
    Developed by the Hepatitis C Coaltiion on the basis of interviews with patient and clinical experts, as well as drawing upon the expertise within the Hepatitis C Coalition’s membership, this fact-sheet provides an overview of the linkages between hepatitis C and HIV. As well as detailing the interactions between the two conditions, it also details the health impact, as well as the latest relevant policy developments.
    UK Aug 2015 Other, Reports & Research PDF
  • Fact-sheet on thalassaemia and hepatitis C
    Developed by the Hepatitis C Coaltiion on the basis of interviews with patient and clinical experts, as well as drawing upon the expertise within the Hepatitis C Coalition’s membership, this fact-sheet provides an overview of the linkages between hepatitis C and thalassaemia. As well as detailing the interactions between the two conditions, it also details the health impact, as well as the latest relevant policy developments.
    UK Aug 2015 Other, Reports & Research PDF
  • Fact-sheet on tuberculosis and hepatitis C
    Developed by the Hepatitis C Coaltiion on the basis of interviews with patient and clinical experts, as well as drawing upon the expertise within the Hepatitis C Coalition’s membership, this fact-sheet provides an overview of the linkages between hepatitis C and tuberculosis. As well as detailing the interactions between the two conditions, it also details the health impact, as well as the latest relevant policy developments.
    UK Aug 2015 Other, Reports & Research PDF
  • Financial case for action on liver disease
    This report, produced by the Foundation for Liver Research and endorsed by the Lancet Commission on Liver Disease, examines the financial costs of viral hepatitis, along with alcohol misuse and obesity. The report also carries recommendations, which include improving access to testing for hepatitis C and protecting harm reduction services such as needle exchange and opioid substitution for injecting drug users.
    UK Reports & Research PDF

Pages